Health & Saf. Code, § 111926.3 · Article 7. Labeling and Advertisement

Health & Saf. Code, § 111926.3

Verbatim from the official edition

Not yet in force

Amended by Stats. 2025, Ch. 248, Sec. 44. (AB 8) Effective January 1, 2026. Operative January 1, 2028, pursuant to Section 111921.8.

(a) An industrial hemp product that is a cosmetic shall not be distributed or sold in the state without packaging and labeling on the product that includes all of the following information:

(1) A label, scannable barcode, internet website, or quick response (QR) code linked to the certificate of analysis of the final form extract or the final form product batch by an independent testing laboratory that provides all of the following information:

(A) The product name.

(B) The name of the product’s manufacturer, packer, or distributor, and their address and telephone number.

(D) The concentration of cannabinoids present in the product batch, including, at minimum, total CBD and any marketed cannabinoids.

(E) The levels within the product batch of contaminants, as required in subdivision (c) of Section 111925.2.

(2) The product expiration or best by date, if applicable.

(3) The following statement, “THE FDA HAS NOT EVALUATED THIS PRODUCT FOR SAFETY OR EFFICACY.”

(b) The requirements of this section shall apply to products manufactured 90 days or more after the enactment of this section.

Text — As published in the Legislative Counsel's database, tables dated October 18, 2026 (pubinfo_2025.zip)

(a) An industrial hemp product that is a cosmetic shall not be distributed or sold in the state without packaging and labeling on the product that includes all of the following information:

(A) The product name.

(B) The name of the product’s manufacturer, packer, or distributor, and their address and telephone number.

(D) The concentration of cannabinoids present in the product batch, including, at minimum, total THC and any marketed cannabinoids.

(E) The levels within the product batch of contaminants, as required in subdivision (c) of Section 111925.2.

(2) The product expiration or best by date, if applicable.

(3) The following statement, “THE FDA HAS NOT EVALUATED THIS PRODUCT FOR SAFETY OR EFFICACY.”

(b) The requirements of this section shall apply to products manufactured 90 days or more after the enactment of this section.

Notes and commentary — not statutory text

History

Added by Stats. 2021, Ch. 576, Sec. 10. (AB 45) Effective October 6, 2021. Superseded on January 1, 2028; see amendment by Stats. 2025, Ch. 248.

History (not yet in force)

Amended by Stats. 2025, Ch. 248, Sec. 44. (AB 8) Effective January 1, 2026. Operative January 1, 2028, pursuant to Section 111921.8.

Source of truth

Edition: As published in the Legislative Counsel's database, tables dated October 18, 2026 (pubinfo_2025.zip)
Official file: https://leginfo.legislature.ca.gov/faces/codes_displaySection.xhtml?lawCode=HSC&sectionNum=111926.3.
Text hash: sha256 f576b1e6ca054f111820a879a1b824404dd89b668ef098149accfd0e1696fabc
Composed by: compose_ca.py 2026-10-22: the Legislative Counsel's CAML content files read by a tokenizer (caml_readers.reader_a); an independent xml.etree reading (caml_readers.reader_b) agrees on every section

This section cites

Provisions in this library that the text above cites, as it prints each citation. A range cited as “ss. 61.13-61.16” links its first and last provisions.

Health and Safety Code

Health & Saf. Code, § 111925.2Printed as Section 111925.2

Procedural information only. Not legal advice and not a substitute for the advice of an attorney. Confirm the current text with the official publisher before relying on it.